GSK beats top-line and bottom-line estimates; raises FY25 outlook

* GSK press release [https://www.gsk.com/media/snycbnpn/q3-2025-results-announcement.pdf] (NYSE:GSK [https://seekingalpha.com/symbol/GSK]): Q3 Non-GAAP EPS of £0.55 beats by £0.08.
* Revenue of £8.55B (+4.9% Y/Y) beats by £300M.
* Specialty Medicines sales £3.4 billion (+16%); Respiratory, Immunology & Inflammation £1.0 billion (+15%); Oncology £0.5 billion (+39%); HIV sales £1.9 billion (+12%).
* Vaccines sales £2.7 billion (+2%); Shingrix £0.8 billion (+13%); Meningitis vaccines £0.5 billion (+5%); and Arexvy £0.3 billion (+36%).
* General Medicines sales £2.5 billion (+4%); Trelegy £0.7 billion (+25%).
* Cash generated from operations of £2.5 billion, with free cash flow of £1.2 billion.
* 2025 GUIDANCE UPGRADED NOW EXPECT: • 2025 turnover growth of between 6% to 7% (previously towards the top end of the range of between 3% to 5%); • Core operating profit growth of between 9% to 11% (previously towards the top end of the range of between 6% to 8%); and • Core EPS growth of between 10% to 12% (previously towards the top end of the range of between 6% to 8%). [https://static.seekingalpha.com/uploads/2025/10/29/saupload_Screenshot_2025-10-29_125506.png]

MORE ON GSK

* GSK: Compelling Value, No Red Flags Ahead Of Earnings, Blenrep FDA Decision Soon [https://seekingalpha.com/article/4829174-gsk-compelling-value-no-red-flags-ahead-of-earnings-blenrep-fda-decision-soon]
* GSK's Hidden Growth Engines Beyond HIV And Oncology [https://seekingalpha.com/article/4828903-gsk-hidden-growth-engines-beyond-hiv-oncology]
* GSK: Walmsley Out, Miels In - I'm Watching The CEO Transition From The Sidelines [https://seekingalpha.com/article/4826693-gsk-walmsley-out-miels-in-im-watching-the-ceo-transition-from-the-sidelines]
* GSK secures exclusive rights to Syndivia’s preclinical ADC for advanced prostate cancer [https://seekingalpha.com/news/4508499-gsk-secures-exclusive-rights-to-syndivias-preclinical-adc-for-advanced-prostate-cancer]
* Earnings week ahead: AAPL, MSFT, AMZN, META, GOOG, BA, XOM, CVX, MA, V, PYPL, SOFI, and more [https://seekingalpha.com/news/4508307-earnings-week-ahead-aapl-msft-amzn-meta-goog-ba-xom-cvx-pfe-ma-v-pypl-sofi-and-more]